{
  "primary": "GSK3B",
  "interaction_type": "direct",
  "upstream_interactor": null,
  "mediator_chain": [],
  "depth": 1,
  "support_summary": "Glycogen synthase kinase 3 beta (GSK3B) directly interacts with and phosphorylates ATXN3 at Serine 256. This interaction, confirmed by affinity capture-western and in vitro reconstituted complex assays, regulates the aggregation of ATXN3.",
  "functions": [
    {
      "function": "ATXN3 Aggregation",
      "arrow": "inhibits",
      "cellular_process": "Glycogen synthase kinase 3 beta (GSK3B) is a serine/threonine kinase that directly phosphorylates ATXN3 at the Serine 256 (S256) residue.",
      "effect_description": "The phosphorylation of ATXN3 at S256 by GSK3B is a key regulatory step that prevents the formation of toxic protein aggregates, which are characteristic of Machado-Joseph disease. By maintaining ATXN3 in a monomeric state, this phosphorylation reduces its cytotoxicity.",
      "biological_consequence": [
        "GSK3B directly binds to ATXN3 → GSK3B phosphorylates ATXN3 at Serine 256 → Phosphorylated ATXN3 remains in a monomeric state → Formation of high molecular weight aggregates is prevented → Reduced cytotoxicity associated with polyQ-expanded ATXN3."
      ],
      "specific_effects": [
        "GSK3B-mediated phosphorylation at S256 inhibits the aggregation of polyQ-expanded ATXN3.",
        "An S256A mutant of ATXN3, which cannot be phosphorylated, readily forms high molecular weight aggregates.",
        "A phosphomimetic S256D mutant of ATXN3 remains monomeric, mimicking the effect of phosphorylation.",
        "The molecular chaperone Hsp70 can suppress the aggregation of the non-phosphorylatable S256A mutant."
      ],
      "evidence": [
        {
          "paper_title": "Phosphorylation of ataxin-3 by glycogen synthase kinase 3beta at serine 256 regulates the aggregation of ataxin-3",
          "journal": "Biochemical and Biophysical Research Communications",
          "year": 2007,
          "relevant_quote": "Here we show that S256 site in ataxin-3 is phosphorylated by GSK 3beta. Moreover, S256A mutant of expanded ataxin-3 forms high molecular weight protein aggregation, whereas S256D mutant and expanded ataxin-3 without mutation on this site are monomeric... Our results imply that phosphorylation of serine 256 in ataxin-3 by GSK 3beta regulates ataxin-3 aggregation.",
          "pmid": "17434145"
        }
      ],
      "pathway": {
        "name": "Protein Aggregation Pathway",
        "canonical_name": "Protein Aggregation Pathway",
        "ontology_id": null,
        "ontology_source": null,
        "confidence": 0.8
      },
      "pmids": [
        "17434145"
      ],
      "interaction_effect": "inhibits",
      "interaction_direction": "primary_to_main",
      "function_effect": "inhibition"
    }
  ],
  "arrow": "regulates",
  "direction": "primary_to_main",
  "intent": "regulation",
  "arrows": {
    "main_to_primary": [
      "activates",
      "inhibits"
    ]
  },
  "is_valid": true,
  "mechanism_correction": null,
  "mechanism": "Glycogen synthase kinase 3 beta (GSK3B) is a serine/threonine kinase that directly phosphorylates ATXN3 at the Serine 256 (S256) residue.",
  "effect": "The phosphorylation of ATXN3 at S256 by GSK3B is a key regulatory step that prevents the formation of toxic protein aggregates, which are characteristic of Machado-Joseph disease. By maintaining ATXN3 in a monomeric state, this phosphorylation reduces its cytotoxicity.",
  "summary": "ATXN3 inhibits GSK3B to modulate atxn3 aggregation, ultimately affecting reduced cytotoxicity associated with polyq-expanded atxn3.",
  "evidence": [
    {
      "paper_title": "Phosphorylation of ataxin-3 by glycogen synthase kinase 3beta at serine 256 regulates the aggregation of ataxin-3",
      "journal": "Biochemical and Biophysical Research Communications",
      "year": 2007,
      "relevant_quote": "Here we show that S256 site in ataxin-3 is phosphorylated by GSK 3beta. Moreover, S256A mutant of expanded ataxin-3 forms high molecular weight protein aggregation, whereas S256D mutant and expanded ataxin-3 without mutation on this site are monomeric... Our results imply that phosphorylation of serine 256 in ataxin-3 by GSK 3beta regulates ataxin-3 aggregation."
    }
  ],
  "pathways": [
    {
      "name": "Protein Aggregation Pathway",
      "canonical_name": "Protein Aggregation Pathway",
      "ontology_id": null,
      "ontology_source": null,
      "confidence": 0.8
    }
  ],
  "interaction_effect": "regulation",
  "_validation_metadata": {
    "validated": true,
    "validator": "arrow_effect_validator",
    "corrections_applied": 3
  },
  "_arrow_validated": true,
  "arrow_notation": "ATXN3 <--regulates-- GSK3B:",
  "protein_a": "ATXN3",
  "protein_b": "GSK3B",
  "discovered_in_query": "ATXN3",
  "first_discovered": "2025-12-01T05:51:49.792575Z",
  "last_updated": "2025-12-01T05:51:49.792575Z"
}